• Aucun résultat trouvé

Management, Health Policy and Economics, France, Doctorate Degree

N/A
N/A
Protected

Academic year: 2022

Partager "Management, Health Policy and Economics, France, Doctorate Degree "

Copied!
2
0
0

Texte intégral

(1)

Maria Laura SILVA

September, 2015

@ [email protected]

' +33 6 36 60 16 03 https://fr.linkedin.com/in/marialaurasilva

* 19, Rue des Vignobles, 33700 Bordeaux, France Page 1/2

Profile:

Through experiencing professional and academic activities in different countries, I developed the ability to work in a team or alone, motivated by a challenge. I am currently working as a post-doctoral fellow at the University of Bordeaux.

Qualification description:

University Lumière Lyon 2, France, 10/2011 — 03/2016, Doctoral School of Economics &

Management, Health Policy and Economics, France, Doctorate Degree

ð

200 pages doctoral thesis on the role of information in decision-making, applied to seasonal influenza vaccination policy – managed deadlines, liaised with thesis’ supervisors and tutors in France and Netherlands; developed qualitative (NVivo®) and quantitative (Stata®) analytical and research skills.

University Claude Bernard Lyon 1, France, 10/2009 — 07/2010, Health Policy Analysis, Tools for decision-making, Public Health, Master’s Degree

ð

120 pages dissertation on the use of economic evaluations in health decision-making — systematic literature review of health systems and policies in the world; developed ability of synthesis, and efficient and orderly approach to tasks.

University Newton Paiva, Brazil, 09/2006 — 11/2007, Quality Assurance and Regulatory Affairs, Quality Control of pharmaceuticals, Post-Bachelor’s Degree

University Newton Paiva, Brazil, 02/2002 — 09/2006, PharmD. (Doctor of Pharmacy), Industrial Pharmacy, Bachelor’s Degree

ð

50 pages dissertation on the structure chart for documents transferring to the Central Archive of Novo Nordisk Pharmaceutical Production of Brazil, available on the University Library.

Work history:

University of Bordeaux, France, 09/2015 – present, Post-doctorate fellow

ð

I’m responsible for research and teaching activities. Main research fields: economics of antibiotics resistance and adverse effects and the French reimbursement of orphan drugs. Teaching activities:

undergraduate Pharmacy students and masters’ degree students

Open Rome, France, 10/2010 — 04/2013, Project leader

ð

I helped conduct a project on the burden of influenza (IBGP), which resulted in the collaboration of Spain, France, Holland, Slovenia, Portugal and Turkey and two years financing of GSK Biologicals. This in turn led to an efficient exchange of clinical and economic data on influenza between those countries.

NIVEL, Netherlands, 06/2012 — 09/2012, Intern PhD candidate

ð

I developed the ability of using the software Stata® to develop the statistical analysis of the IBGP study, which resulted in a publication in the BMC Public Health journal.

Department of Health and Pharmaceutical Logistics of the State of Minas Gerais, Brazil, 09/2006

— 09/2009, Health Policy Analyst

ð

I developed technical reports, which resulted in the optimization of the drug logistics between the State and its municipalities; and improved the management of reception and distribution of orphan and high cost drugs from the Ministry of Health and other Departments of Health over the country.

Novo Nordisk Pharmaceutical Production, Brazil, 02/2006 — 08/2006, Trainee Analyst ð

I developed Standard Operational Procedures for the Central Archive that enabled good standard

practices for the new system of documentation management. I also contributed to the routine of documents control and changing alterations, and regulatory affairs.

(2)

Maria Laura SILVA

September, 2015

@ [email protected]

' +33 6 36 60 16 03 https://fr.linkedin.com/in/marialaurasilva

* 19, Rue des Vignobles, 33700 Bordeaux, France Page 2/2

Publications on peer-review journals:

*Silva ML, Paget JW, Mosnier A, Buthion V, Cohen JM, Perrier L, Späth HM (2016). Development of seasonal influenza vaccination recommendations: relevance and influence of the evidence on the decision-making process in France and The Netherlands. Value in Health. 2016 Jul-

Aug;19(5):670-9. doi: 10.1016/j.jval.2016.02.006.

*Silva ML, Perrier L, Paget JW, Mosnier A, Buthion V, Cohen JM, Späth HM (2016). Influenza vaccination policy-making processes in France and The Netherlands: framework and determinants.

Health Policy. 2016 Mar;120(3):293-305. doi: 10.1016/j.healthpol.2016.01.005.

*Silva ML, Perrier L, Cohen JM, Paget WJ, Mosnier A, Späth HM. A literature review to identify factors that determine policies for influenza vaccination. Health Policy. 2015 Jun 1;119(6):697–708.

*Silva ML, Perrier L, Späth HM, Grog I, Mosnier A, Havet N, Cohen JM. Economic burden of seasonal influenza B in France during winter 2010-2011. BMC Public Health. 2014 Jan 20;14(1):56.

*Silva ML, Perrier L, Moumjid NF, Späth HM. The use of economic evaluations in health decision- making at the macro level: a literature review. Journal de gestion et d'économie médicales, 2012, 30 (4), pp. 231-251.

Latest communications:

*Poster presentation in English at the ISPOR 19th Annual European Congress, Vienne, 31 Oct 2016 - General practitioners perceptions about financial and non­financial incentives to improve influenza vaccination coverage rates in France.

*Oral presentation in English at the ISPOR 17th Annual European Congress, Amsterdam, 10 Nov 2014 - Information used in the decision-making process regarding influenza vaccination policy:

perceptions of stakeholders in France and The Netherlands.

*Poster presentation in English at the European Health Economics Association PhD Student- Supervisor Conference, Manchester, 02 Sept 2014 - Analysis of Decision-Making in Influenza Vaccination Policy: common points and differences in France and the Netherlands.

*Oral presentation in French in the XVIème Journée Scientifique Nationale du Réseau des GROG, Paris, 26 Janv 2012 - IBGP : Étude Européenne du fardeau de la grippe B en médecine

ambulatoire.

Languages:

English (fluent), French (fluent), Spanish (advanced), Portuguese (native).

References:

Dr John Paget, PhD, Senior Researcher, [email protected]

Dr Lionel Perrier, PhD, Health Economist, [email protected]

Dr Hans-Martin Späth, Associate Professor, [email protected] Dr Augusto Guerra, Associate Professor, [email protected]

Dr Liziane Silva, Director, [email protected]

Références

Documents relatifs

Specifically, the thesis explicitly recognises that any test of the APT is a joint hypothesis between the properties of the APT and first, the structure of the return

INSTRUMENTAL MEDICAL ALTRUISM: PARADOXES OF ECONOMIC THEORY AND PROBLEMS OF ECONOMIC POLICY This conception of ethics, which reduces ethics to altruism and reduces altruism

The 803 OHS professionals surveyed said that in addition to raising staff awareness, their main difficulties related to the management of regulatory compliance and the

T he Health, Health Care and Insurance Survey (ESPS) is a general population survey carried out by IRDES since 1988 that collects informa- tion on individuals’ health

La section 37 du Comité National de la Recherche Scientifique présente dans le document qui suit sa liste mise à jour en juin 2008 des revues à comité de lecture dans

This is made clear in the mandate given to the Health Commissioner, which outlines how he should develop expertise to ‘inform’ national and EU level policies and contribute to the

• to illustrate the extent to which an economic argument can be made in favour of investment in three major social determinants of health areas: education, social protection,

The resource book reviews and discusses the existing evidence in three major areas of social determinants of health: education, social protection, and urban development, housing